Asset Details
Do you wish to reserve the book?
An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases
Do you wish to request the book?
An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases
2019
Overview
Natural compounds, in recent years, have attracted significant attention for their use in the prevention and treatment of diverse chronic diseases as they are devoid of major toxicities. Boswellic acid (BA), a series of pentacyclic triterpene molecules, is isolated from the gum resin of Boswellia serrata and Boswellia carteri. It proved to be one such agent that has exhibited efficacy against various chronic diseases like arthritis, diabetes, asthma, cancer, inflammatory bowel disease, Parkinson’s disease, Alzheimer’s, etc. The molecular targets attributed to its wide range of biological activities include transcription factors, kinases, enzymes, receptors, growth factors, etc. The present review is an attempt to demonstrate the diverse pharmacological uses of BA, along with its underlying molecular mechanism of action against different ailments. Further, this review also discusses the roadblocks associated with the pharmacokinetics and bioavailability of this promising compound and strategies to overcome those limitations for developing it as an effective drug for the clinical management of chronic diseases.
Publisher
MDPI AG,MDPI
Subject
/ Animals
/ Anti-Inflammatory Agents, Non-Steroidal - administration & dosage
/ Anti-Inflammatory Agents, Non-Steroidal - chemistry
/ Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics
/ Anti-Inflammatory Agents, Non-Steroidal - pharmacology
/ Antineoplastic Agents, Phytogenic - administration & dosage
/ Antineoplastic Agents, Phytogenic - chemistry
/ Antineoplastic Agents, Phytogenic - pharmacokinetics
/ Antineoplastic Agents, Phytogenic - pharmacology
/ Chronic Disease - drug therapy
/ Humans
/ Kinases
/ Mice
/ Plant Extracts - administration & dosage
/ Plant Extracts - pharmacokinetics
/ Plant Extracts - pharmacology
/ Review
/ Structure-Activity Relationship
/ Triterpenes - administration & dosage
